#USA #New York #Class Action #Pomerantz LLP #GPGI

Investor Alert: Class Action Lawsuit Against GPGI, Inc.

On July 23, 2026, the Pomerantz Law Firm made significant headlines by announcing a class action lawsuit aimed at GPGI, Inc., a company traded on the NYSE under the ticker symbol GPGI. This legal action is crucial for investors who have incurred losses in their investments during the relevant class period. If you're among those impacted, it’s important to act promptly and determine your eligibility for potential compensation. Investors are encouraged to reach out to Danielle Peyton at Pomerantz LLP via email or phone for more details.

The class action primarily addresses allegations that GPGI, alongside certain officers and directors, may have engaged in securities fraud or other illicit business activities. Affected investors should be aware of the deadlines for submitting their claims; the cutoff date to request appointment as Lead Plaintiff is September 14, 2026.

For those interested in understanding the context of these allegations, recent financial disclosures by GPGI have raised concerns. On March 12, 2026, the company released its financial results for the fourth quarter of fiscal year 2025, revealing net sales of $520.8 million for this period. Although this marked a year-over-year increase of 6.1%, the company also disclosed a decline in Pro Forma Adjusted EBITDA, which fell to $136.1 million—a decrease of 5.4% from the previous year. This decline was further compounded by a significant squeeze in EBITDA margins, which dropped from 29.3% in Q4 of 2025 to 26.1%.

Following this announcement, GPGI's stock witnessed a sharp decline, plummeting by $3.23 per share or 16.36%, ending at $16.51 on March 13, 2026. This steep decline raised investor concerns about the company’s financial health and practices.

The situation worsened when GPGI released its financial results for the first quarter of 2026 on May 7, 2026. The figures illustrated a worrying trend, with Pro Forma Adjusted Net Sales falling to $290.8 million—down 5.2% year-over-year—and Pro Forma Adjusted EBITDA dropping to $38 million, a staggering 40.2% decrease compared to the prior year. Furthermore, GPGI revised its guidance for 2026 downward, reflecting a more pessimistic outlook on its financial performance. The company's initial projections for Pro Forma Adjusted Net Sales were cut from a range of $2.183 billion to $2.228 billion down to $1.95 billion to $2.10 billion, and the Pro Forma Adjusted EBITDA guidance was similarly reduced.

The reaction to this news was swift; GPGI shares fell by $4.52 or 25.89%, closing at $12.94 per share on the same day. Such significant drops in stock price, coupled with the legal ramifications of the class action, highlight the severe implications for GPGI and its stakeholders.

Pomerantz LLP, known for its specialization in corporate and securities class litigation, has a venerable history of advocating for investor rights. The firm has been at the forefront of fighting against securities fraud, breaches of fiduciary duty, and corporate misconduct for over 85 years. If you find yourself as an affected investor, remember to visit their website or contact them directly for specific instructions on how to proceed with your claim.

In conclusion, the unfolding events surrounding GPGI, Inc. are a reminder of the volatility in the investment environment and the necessity for vigilance among investors. Staying informed and responsive to such legal notices may impact the overall recovery from investment losses.

For further information and assistance, potential plaintiffs can check Pomerantz LLP's official communication channels.